Novel use of ultrasound-guided transgluteal sciatic nerve block to treat severe herpes zoster pain along the S1 dermatome

Am J Emerg Med. 2023 Sep:71:250.e5-250.e8. doi: 10.1016/j.ajem.2023.05.014. Epub 2023 May 23.

Abstract

Patients presenting with herpes zoster (HZ) to emergency departments (EDs) across the United States represent a significant number of visits and have pain that is difficult to manage, sometimes even requiring opioid medications for adequate analgesia. Ultrasound-guided nerve blocks (UGNBs) are becoming more integrated into the ED physician's tool box for a multimodal approach to analgesia in various indications. Here we describe a novel use of the transgluteal sciatic UGNB for treatment of HZ pain along the S1 dermatome. A 48-year-old woman presented to the ED with right-sided leg pain associated with a HZ rash. After initially failing non-opioid pain management, the ED physician performed a transgluteal sciatic UGNB for our patient, leading to successful complete resolution of her pain, with no adverse effects reported. Our case highlights the potential role of using the transgluteal sciatic UGNB for analgesia related to HZ-related pain, as well as its potential opioid-sparing benefits. Although UGNBs require a baseline understanding of ultrasound technique for procedural guidance, this skillset has recently been incorporated as core competency within emergency medicine training in the United States. UGNBs should therefore be considered in the multimodal analgesic armamentarium for the ED treatment of HZ pain.

Keywords: Herpes zoster; Ultrasound-guided nerve block.

Publication types

  • Case Reports

MeSH terms

  • Analgesics, Opioid / therapeutic use
  • Female
  • Herpes Zoster* / drug therapy
  • Herpes Zoster* / therapy
  • Humans
  • Middle Aged
  • Pain / drug therapy
  • Pain Management / methods
  • Sciatic Nerve / diagnostic imaging
  • Ultrasonography, Interventional* / methods

Substances

  • Analgesics, Opioid